SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Eris Lifesciences - Quaterly Results

17 Jan 2023 Evaluate
The December 2022 quarter revenue stood at Rs. 3320.12 millions, up 8.99% as compared to Rs. 3046.31 millions during the corresponding quarter last year.Net profit declined -4.49% to Rs. 993.79 millions from Rs. 1040.55 millions.OP of the company witnessed a marginal growth to 1298.68 millions from 1286.19 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 3320.12 3046.31 8.99 10161.41 9335.88 8.84 12157.30 11088.34 9.64
Other Income 34.79 58.36 -40.39 130.04 199.37 -34.77 289.89 99.98 189.95
PBIDT 1298.68 1286.19 0.97 4066.28 4023.08 1.07 5129.84 4273.12 20.05
Interest 31.42 7.65 310.72 178.54 20.14 786.49 29.91 7.78 284.45
PBDT 1267.26 1278.54 -0.88 3887.74 4002.94 -2.88 5099.93 4265.34 19.57
Depreciation 164.97 135.37 21.87 473.73 363.85 30.20 514.55 376.40 36.70
PBT 1102.29 1143.17 -3.58 3414.01 3639.09 -6.19 4585.38 3888.94 17.91
TAX 108.50 102.62 5.73 312.34 334.26 -6.56 413.46 382.89 7.98
Deferred Tax -83.77 -128.29 -34.70 -282.57 -394.50 -28.37 -388.26 -318.95 21.73
PAT 993.79 1040.55 -4.49 3101.67 3304.83 -6.15 4171.92 3506.05 18.99
Equity 135.99 135.93 0.04 135.99 135.93 0.04 135.93 135.78 0.11
PBIDTM(%) 39.12 42.22 -7.36 40.02 43.09 -7.14 42.20 38.54 9.49

Eris Lifesciences Share Price

1435.30 -11.20 (-0.77%)
20-Apr-2026 15:16 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.70
Dr. Reddys Lab 1231.60
Cipla 1230.10
Zydus Lifesciences 938.00
Lupin 2328.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×